1259MO Encorafenib plus binimetinib in patients (pts) with previously untreated BRAF V600E-mutant advanced non-small cell lung cancer (NSCLC): An open-label, multicenter phase II trial (IFCT-1904 ENCO-BRAF)

David Planchard, J. Mazieres, C. Mascaux, F. Guisier, Pascale Tomasini, Marie Wislez, D. Moro-Sibilot, S. Cousin, A.B. Cortot, S. Couraud, Vincent Fallet, Camille Guguen, Anaïs Lagrange, A-C. Madroszyk Flandin, Josiane Otto, M. Pérol, Benoît Roch, E. Amour, Françoise Morin, C. Ricordel